2019
DOI: 10.3389/fgene.2019.00317
|View full text |Cite
|
Sign up to set email alerts
|

Single-Cell RNA-Seq Technologies and Related Computational Data Analysis

Abstract: Single-cell RNA sequencing (scRNA-seq) technologies allow the dissection of gene expression at single-cell resolution, which greatly revolutionizes transcriptomic studies. A number of scRNA-seq protocols have been developed, and these methods possess their unique features with distinct advantages and disadvantages. Due to technical limitations and biological factors, scRNA-seq data are noisier and more complex than bulk RNA-seq data. The high variability of scRNA-seq data raises computational challenges in dat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
544
0
3

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 708 publications
(593 citation statements)
references
References 127 publications
1
544
0
3
Order By: Relevance
“…In consideration of the trade-offs among the large number of methods evaluated with our limited time, computational resources, and manpower, we carefully selected realworld datasets for the benchmarking. The latest scRNA-seq methods are divided into two categories, namely, full-length scRNA-seq methods and high-throughput scRNA-seq methods with specific cell dissociation and cellular/molecular barcoding technologies such as droplet-based and split-and-pool experiments [34,35]. Because the number of cells measured by scRNA-seq has been increased by the latter technology, we selected the following four datasets generated by such technologies: human peripheral blood mononuclear cells (PBMCs), human pancreatic cells (Pancreas), mouse brain and spinal cord (BrainSpinalCord), and mouse cells from the cortex, hippocampus, and ventricular zone (Brain) ( Table 2).…”
Section: Real-world Datasetsmentioning
confidence: 99%
“…In consideration of the trade-offs among the large number of methods evaluated with our limited time, computational resources, and manpower, we carefully selected realworld datasets for the benchmarking. The latest scRNA-seq methods are divided into two categories, namely, full-length scRNA-seq methods and high-throughput scRNA-seq methods with specific cell dissociation and cellular/molecular barcoding technologies such as droplet-based and split-and-pool experiments [34,35]. Because the number of cells measured by scRNA-seq has been increased by the latter technology, we selected the following four datasets generated by such technologies: human peripheral blood mononuclear cells (PBMCs), human pancreatic cells (Pancreas), mouse brain and spinal cord (BrainSpinalCord), and mouse cells from the cortex, hippocampus, and ventricular zone (Brain) ( Table 2).…”
Section: Real-world Datasetsmentioning
confidence: 99%
“…However, these techniques pose further technical and economic challenges (88,89). Specifically, a large number of organoids must be sequenced to mitigate cellular complexity and batch heterogeneity and powerful, reproducible and accurate computational pipelines are required to analyse such data (90).…”
Section: Discussionmentioning
confidence: 99%
“…The advent of scRNA-seq has been heralded as a revolution promising new approaches to classification of myeloid heterogeneity [35,157,158]. Single cell (sc) RNA-seq is intrinsically noisy, non-quantitative stochastic sampling of a subset of the most abundant mRNAs in individual cells ( [159,160]). Algorithms that support non-linear dimensional reduction (e.g.…”
Section: The Relationship Between Single Cell and Bulk Rna-seq Datamentioning
confidence: 99%